Cargando...

Studies on Fragment-Based Design of Allosteric Inhibitors of Human Factor XIa

Human factor XIa (hFXIa) has emerged as an attractive target for development of new anticoagulants that promise higher level of safety. Different strategies have been adopted so far for the design of anti-hFXIa molecules including competitive and non-competitive inhibition. Of these, allosteric dysf...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Bioorg Med Chem
Main Authors: Boothello, Rio S., Sankaranarayanan, Nehru Viji, Afosah, Daniel K., Karuturi, Rajesh, Al-Horani, Rami A., Desai, Umesh R.
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8109618/
https://ncbi.nlm.nih.gov/pubmed/32992249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2020.115762
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!